vs
FirstCash Holdings, Inc.（FCFS）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是FirstCash Holdings, Inc.的1.1倍（$540.7M vs $501.3M），FirstCash Holdings, Inc.净利率更高（20.8% vs -2.9%，领先23.7%），FirstCash Holdings, Inc.同比增速更快（21.2% vs -14.1%），过去两年FirstCash Holdings, Inc.的营收复合增速更高（16.9% vs -2.3%）
FirstCash Holdings, Inc.是总部位于美国得克萨斯州沃斯堡的典当企业，在美国及拉丁美洲多地运营线下典当零售门店，为纳斯达克证券交易所公开上市企业，在美洲典当服务领域拥有成熟的业务布局与完善的运营网络。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
FCFS vs ICUI — 直观对比
营收规模更大
ICUI
是对方的1.1倍
$501.3M
营收增速更快
FCFS
高出35.3%
-14.1%
净利率更高
FCFS
高出23.7%
-2.9%
两年增速更快
FCFS
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $501.3M | $540.7M |
| 净利润 | $104.2M | $-15.7M |
| 毛利率 | — | 37.5% |
| 营业利润率 | 28.5% | 1.0% |
| 净利率 | 20.8% | -2.9% |
| 营收同比 | 21.2% | -14.1% |
| 净利润同比 | 24.7% | 34.0% |
| 每股收益（稀释后） | $2.35 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCFSICUI
| Q4 25 | $501.3M | $540.7M | ||
| Q3 25 | $411.0M | $537.0M | ||
| Q2 25 | $385.1M | $548.9M | ||
| Q1 25 | $371.1M | $604.7M | ||
| Q4 24 | $413.7M | $629.8M | ||
| Q3 24 | $363.1M | $589.1M | ||
| Q2 24 | $363.5M | $596.5M | ||
| Q1 24 | $366.8M | $566.7M |
净利润FCFSICUI
| Q4 25 | $104.2M | $-15.7M | ||
| Q3 25 | $82.8M | $-3.4M | ||
| Q2 25 | $59.8M | $35.3M | ||
| Q1 25 | $83.6M | $-15.5M | ||
| Q4 24 | $83.5M | $-23.8M | ||
| Q3 24 | $64.8M | $-33.0M | ||
| Q2 24 | $49.1M | $-21.4M | ||
| Q1 24 | $61.4M | $-39.5M |
毛利率FCFSICUI
| Q4 25 | — | 37.5% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 37.9% | ||
| Q1 25 | — | 34.7% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 34.8% | ||
| Q1 24 | — | 32.7% |
营业利润率FCFSICUI
| Q4 25 | 28.5% | 1.0% | ||
| Q3 25 | 27.4% | 2.6% | ||
| Q2 25 | 21.1% | 1.9% | ||
| Q1 25 | 30.0% | 2.1% | ||
| Q4 24 | 26.5% | 6.0% | ||
| Q3 24 | 23.5% | 1.4% | ||
| Q2 24 | 18.2% | 1.3% | ||
| Q1 24 | 22.3% | -1.9% |
净利率FCFSICUI
| Q4 25 | 20.8% | -2.9% | ||
| Q3 25 | 20.1% | -0.6% | ||
| Q2 25 | 15.5% | 6.4% | ||
| Q1 25 | 22.5% | -2.6% | ||
| Q4 24 | 20.2% | -3.8% | ||
| Q3 24 | 17.9% | -5.6% | ||
| Q2 24 | 13.5% | -3.6% | ||
| Q1 24 | 16.7% | -7.0% |
每股收益（稀释后）FCFSICUI
| Q4 25 | $2.35 | $-0.63 | ||
| Q3 25 | $1.86 | $-0.14 | ||
| Q2 25 | $1.34 | $1.43 | ||
| Q1 25 | $1.87 | $-0.63 | ||
| Q4 24 | $1.86 | $-0.97 | ||
| Q3 24 | $1.44 | $-1.35 | ||
| Q2 24 | $1.08 | $-0.88 | ||
| Q1 24 | $1.35 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.2M | — |
| 总债务越低越好 | $2.2B | — |
| 股东权益账面价值 | $2.3B | $2.1B |
| 总资产 | $5.3B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.98× | — |
8季度趋势，按日历期对齐
现金及短期投资FCFSICUI
| Q4 25 | $125.2M | — | ||
| Q3 25 | $130.2M | — | ||
| Q2 25 | $101.5M | — | ||
| Q1 25 | $146.0M | — | ||
| Q4 24 | $175.1M | $308.6M | ||
| Q3 24 | $106.3M | $312.5M | ||
| Q2 24 | $113.7M | $302.6M | ||
| Q1 24 | $135.1M | $251.4M |
总债务FCFSICUI
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.5B | — |
股东权益FCFSICUI
| Q4 25 | $2.3B | $2.1B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.1B | $2.0B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.0B | $2.0B | ||
| Q1 24 | $2.0B | $2.1B |
总资产FCFSICUI
| Q4 25 | $5.3B | $4.1B | ||
| Q3 25 | $5.2B | $4.1B | ||
| Q2 25 | $4.5B | $4.1B | ||
| Q1 25 | $4.4B | $4.2B | ||
| Q4 24 | $4.5B | $4.2B | ||
| Q3 24 | $4.4B | $4.3B | ||
| Q2 24 | $4.3B | $4.3B | ||
| Q1 24 | $4.2B | $4.3B |
负债/权益比FCFSICUI
| Q4 25 | 0.98× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 0.79× | — | ||
| Q1 25 | 0.83× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $206.6M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 4.6% |
| 现金转化率经营现金流/净利润 | 1.98× | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流FCFSICUI
| Q4 25 | $206.6M | $60.6M | ||
| Q3 25 | $135.8M | $56.7M | ||
| Q2 25 | $116.9M | $11.2M | ||
| Q1 25 | $126.6M | $51.3M | ||
| Q4 24 | $198.1M | $40.2M | ||
| Q3 24 | $113.1M | $36.1M | ||
| Q2 24 | $106.2M | $82.0M | ||
| Q1 24 | $122.5M | $45.8M |
自由现金流FCFSICUI
| Q4 25 | — | $36.0M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $-8.5M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $62.5M | ||
| Q1 24 | — | $29.9M |
自由现金流率FCFSICUI
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 5.3% |
资本支出强度FCFSICUI
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 2.8% |
现金转化率FCFSICUI
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.64× | — | ||
| Q2 25 | 1.95× | 0.32× | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | 2.37× | — | ||
| Q3 24 | 1.74× | — | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 2.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
